VivoSeq
Other

Abortion

80

Pipeline Programs↗

9

Active Trials↗

23

Companies Involved↗

Abortion is a moderately active landscape with 80 programs across 23 companies. The most active players are Viatris Specialty LLC, Acacia Pharma Ltd, Bioenvision. 35 therapies are approved with 12 more in late-stage development.

Intelligence

Pipeline Metrics

Competitive Density

67/100

Pipeline Velocity

0/100

Mech. Concentration

14/100

Completion Rate

82/100

Attrition Rate

14/100

Competition

Competitive Landscape

Bubble size = clinical trials

Approved
Phase 3
Phase 2
Phase 1
Preclinical

Key Players

Top Companies Companies ranked by the number of pipeline programs they run for this disease.

V

Viatris Specialty LLC

1 program

Phase 1A

Acacia Pharma Ltd

1 program

Phase 2B

Bioenvision

1 program

Phase 2Boehringer Ingelheim logo

Boehringer Ingelheim

1 program

Phase 3K

Kenvue Brands

1 program

Phase 3P

Protega

1 program

Phase 3

Pipeline

Programs by Phase

Analysis

Trial Status

132

clinical trials

Completed85 · 64%
Unknown status19 · 14%
Terminated15 · 11%
Recruiting7 · 5%
Withdrawn3 · 2%
Not yet recruiting2 · 2%
Other1 · 1%

Clinical Trials

Trial Activity

132 trials

Comparison of Rate of Complete Abortion Between Letrozole Plus Misoprostol vs Misoprostol Alone
Recruiting·QQueen Savang Vadhana Memorial Hospital, Thailand·N/A·NCT05940233·70 enrolled
Pharmacological Inhibition of Lactation After 16 to 20 Week Abortion
Recruiting·NNorthwestern University·Phase 4·NCT06123026·200 enrolled
A Real-World Study Comparing the Efficacy of Different Treatment Regimens for Early Missed Abortion
Recruiting·TThe Third Xiangya Hospital of Central South University·N/A·NCT07422506·580 enrolled
Study on the Effect of Combined Estrogen and Progestogen Therapy on Endometrial Repair After Induced Abortion
Recruiting·WWomen's Hospital School Of Medicine Zhejiang University·Phase 1·NCT06546397·200 enrolled
Prevalence of Intrauterine Adhesions After D&C With or Without Antiadhesion Gel After Abortion in Second Trimester.
Recruiting·IInstitute for the Care of Mother and Child, Prague, Czech Republic·Phase 4·NCT04671914·200 enrolled
Evaluation of Telemedicine Medical Abortion Service in Ecuador
Recruiting·GGynuity Health Projects·N/A·NCT06270056·100 enrolled
Effectiveness of Anti-Inflammatory Drugs for Preventing Pain Versus Treating Pain During Medical Abortion From 13 to 22 Weeks at Hung Vuong Hospital
Recruiting·LLe Thi Kieu Trang·N/A·NCT06696573·180 enrolled
Misoprostol in Missed Abortion
Not yet recruiting·—·N/A·NCT06818903·122 enrolled
Effect of Oxycodone on Anxiety State in Painless Abortion
Not yet recruiting·RRuijin Hospital·Phase 1·NCT06435949·300 enrolled
Paracervical Block During II-trimester Abortion
Completed·—·N/A·NCT01617564·112 enrolled
Comparing Two Regimens for Medical Abortion: Mifepristone + Misoprostol Versus Misoprostol Alone
Completed·GGynuity Health Projects·Phase 4·NCT01387256·441 enrolled
A Randomized Controlled Trial of Three Antibiotic Regimens for First Trimester Abortions
Completed·MMedstar Health Research Institute·N/A·NCT02756403·181 enrolled
Dextromethorphan as a Novel Non-opioid Adjunctive Agent for Pain Control in Medication Abortion
Completed·—·Phase 3·NCT03480009·156 enrolled
Uptake and Acceptability of Home-use of Mifepristone for Medical Abortion
Completed·GGynuity Health Projects·N/A·NCT00994734·615 enrolled
Misoprostol Dose and Timing Before Surgical Abortion at 13 to 16 Weeks' Gestation: a Randomized Trial
Completed·PPlanned Parenthood of Greater New York·N/A·NCT02279914·118 enrolled
Page 1 of 9

Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)